The FDA has approved a Bayer drug to reduce the recurrence of stroke, the first in a novel class of medications designed to prevent blood clots without increasing the risk of bleeding. STAT
STATFDA approves novel Bayer drug to reduce recurrence of strokeBayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.
What evidence would you want to see before treating "no added bleeding risk" as settled?